SpaceX Scrubs Starship Test Flight Hours After Releasing IPO Prospectus Retry Scheduled for Friday Global Infrastructure Funding Surges as Japanese Banks Lead FiveYear Doubling Telsey Advisory Group Highlights Lowes Resilience Amid Housing Market Challenges Wall Street Mixed as Oil Prices Slide on Iran Deal Hopes Micron Surges 56 GlobalFoundries Falls 9 Karnataka Extends 2847 Crore Support as BengaluruBidar Kalaburagi Flights to Resume in June Amazon Health Chief Steps Down Amwell Cofounder Dr Roy Schoenberg to Take Over Nutex Health Inc NUTX Q1 2026 Earnings EPS Surges Past Estimates CWEN Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement Soligenix SNGX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Slips Arrow Financial Q1 2026 Earnings EPS Beats Estimates by 176 Brookfield Asset Management Inc BAM Q1 2026 Earnings Slight EPS Miss Amid Stable Operations DGICB Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Underwriting Environment Destiny Tech100 Inc DXYZ Gains 219 as Shares Approach Key Resistance Zone Lifetime Brands LCUT Shares Dip as Support Level Approaches Key Levels to Watch Calamos Global Total Return Fund CGO Gains Ground as Price Approaches Key Resistance Healthcare Realty Trust HR Edges Lower Holds Above Key Support Riley Exploration Permian Faces Headwinds as Shares Decline Nearly 6 REPX Technicals Test Key Support SherwinWilliams SHW Q1 2026 Earnings Solid EPS Beat Amidst Mixed Demand Signals Fluent Inc Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty T1 Energy Inc Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Absence GEO Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction HEPS Q1 2026 Earnings Negative EPS Weighs on Stock Amid Ongoing Operational Challenges ROP Q1 2026 Earnings EPS Surpasses Estimates by 258 Amid Solid Operational Performance Gen Z Faces Economic Instability Despite Higher Education Report Shows Dream Finders Homes Inc DFH Q1 2026 Earnings EPS Miss and Stock Decline Amid Housing Market Headwinds PDS Biotechnology PDSB Edges Higher by 182 as Biotech Speculative Interest Persists